The Europe Pharmaceutical Gelatin Market should witness market growth of 5.1% CAGR during the forecast period (2022-2028).
To minimize loss of blood during surgery, surgeons use gelatin as it is a widely available hemostatic agent. Gelatin-based hemostats are majorly produced from gelatin derived from porcine collagen (pork skin). These gelatin-based hemostats are used in the form of sponges, strips, powder, or nanofibers.
The high capability of absorption, which is almost forty times their own weight, makes them perfect to be used in creating an artificial blood clot and stemming blood flow. When combined with thrombin, gelatin-based hemostats facilitate the formation of blood clots. Due to their highly biocompatible property, gelatin sponges naturally dissolve when left in the body. Specific dissolution rates are required in some of the Vivo applications in order to configure the gelatin sponges in a specific way to meet the requirements of the individual.
Gelatin is also used in the manufacturing of medical devices such as Femoral plugs, which are the devices used in hip replacements. Gelatin can be used with a plasticizer to make femoral plugs more elastic. They are used in helping the alteration of the prosthesis. When the plaster sets, it secures the tissues from exothermic reactions. It is easier for the body to absorb because of the properties it possesses, such as biocompatibility, low immunogenicity, and more biodegradability.
The National Health Services (NHS), launched in 1948, is the world's most extensive joint healthcare system. It treats around 1 million patients daily. It was created to provide healthcare to all and is free for all UK citizens. NHA shares more than £100 billion in funds to commission health care services in England and holds the organization to oversee the effective spending of these funds. The expanding healthcare sector and the rising funding will surge the usage of medications with gelatin. This factor is anticipated to propel the market growth for pharmaceutical gelatin in the Europe region.
The Germany market dominated the Europe Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $100.3 million by 2028. The UK market is exhibiting a CAGR of 4.2% during (2022-2028). Additionally, The France market would experience a CAGR of 5.9% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
To minimize loss of blood during surgery, surgeons use gelatin as it is a widely available hemostatic agent. Gelatin-based hemostats are majorly produced from gelatin derived from porcine collagen (pork skin). These gelatin-based hemostats are used in the form of sponges, strips, powder, or nanofibers.
The high capability of absorption, which is almost forty times their own weight, makes them perfect to be used in creating an artificial blood clot and stemming blood flow. When combined with thrombin, gelatin-based hemostats facilitate the formation of blood clots. Due to their highly biocompatible property, gelatin sponges naturally dissolve when left in the body. Specific dissolution rates are required in some of the Vivo applications in order to configure the gelatin sponges in a specific way to meet the requirements of the individual.
Gelatin is also used in the manufacturing of medical devices such as Femoral plugs, which are the devices used in hip replacements. Gelatin can be used with a plasticizer to make femoral plugs more elastic. They are used in helping the alteration of the prosthesis. When the plaster sets, it secures the tissues from exothermic reactions. It is easier for the body to absorb because of the properties it possesses, such as biocompatibility, low immunogenicity, and more biodegradability.
The National Health Services (NHS), launched in 1948, is the world's most extensive joint healthcare system. It treats around 1 million patients daily. It was created to provide healthcare to all and is free for all UK citizens. NHA shares more than £100 billion in funds to commission health care services in England and holds the organization to oversee the effective spending of these funds. The expanding healthcare sector and the rising funding will surge the usage of medications with gelatin. This factor is anticipated to propel the market growth for pharmaceutical gelatin in the Europe region.
The Germany market dominated the Europe Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $100.3 million by 2028. The UK market is exhibiting a CAGR of 4.2% during (2022-2028). Additionally, The France market would experience a CAGR of 5.9% during (2022-2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Scope of the Study
By Type
- Type B
- Type A
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & Others
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pharmaceutical Gelatin Market, by Type
1.4.2 Europe Pharmaceutical Gelatin Market, by Source
1.4.3 Europe Pharmaceutical Gelatin Market, by Function
1.4.4 Europe Pharmaceutical Gelatin Market, by Application
1.4.5 Europe Pharmaceutical Gelatin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Pharmaceutical Gelatin Market
Chapter 4. Europe Pharmaceutical Gelatin Market by Type
4.1 Europe Type B Market by Country
4.2 Europe Type A Market by Country
Chapter 5. Europe Pharmaceutical Gelatin Market by Source
5.1 Europe Porcine Market by Country
5.2 Europe Bovine Skin Market by Country
5.3 Europe Bovine Bone Market by Country
5.4 Europe Marine Market by Country
5.5 Europe Poultry Market by Country
Chapter 6. Europe Pharmaceutical Gelatin Market by Function
6.1 Europe Stabilizing Agent Market by Country
6.2 Europe Thickening Agent Market by Country
6.3 Europe Gelling Agent & Others Market by Country
Chapter 7. Europe Pharmaceutical Gelatin Market by Application
7.1 Europe Hard Capsules Market by Country
7.2 Europe Softgel Capsules Market by Country
7.3 Europe Tablets Market by Country
7.4 Europe Absorbable Hemostats Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Pharmaceutical Gelatin Market by Country
8.1 Germany Pharmaceutical Gelatin Market
8.1.1 Germany Pharmaceutical Gelatin Market by Type
8.1.2 Germany Pharmaceutical Gelatin Market by Source
8.1.3 Germany Pharmaceutical Gelatin Market by Function
8.1.4 Germany Pharmaceutical Gelatin Market by Application
8.2 UK Pharmaceutical Gelatin Market
8.2.1 UK Pharmaceutical Gelatin Market by Type
8.2.2 UK Pharmaceutical Gelatin Market by Source
8.2.3 UK Pharmaceutical Gelatin Market by Function
8.2.4 UK Pharmaceutical Gelatin Market by Application
8.3 France Pharmaceutical Gelatin Market
8.3.1 France Pharmaceutical Gelatin Market by Type
8.3.2 France Pharmaceutical Gelatin Market by Source
8.3.3 France Pharmaceutical Gelatin Market by Function
8.3.4 France Pharmaceutical Gelatin Market by Application
8.4 Russia Pharmaceutical Gelatin Market
8.4.1 Russia Pharmaceutical Gelatin Market by Type
8.4.2 Russia Pharmaceutical Gelatin Market by Source
8.4.3 Russia Pharmaceutical Gelatin Market by Function
8.4.4 Russia Pharmaceutical Gelatin Market by Application
8.5 Spain Pharmaceutical Gelatin Market
8.5.1 Spain Pharmaceutical Gelatin Market by Type
8.5.2 Spain Pharmaceutical Gelatin Market by Source
8.5.3 Spain Pharmaceutical Gelatin Market by Function
8.5.4 Spain Pharmaceutical Gelatin Market by Application
8.6 Italy Pharmaceutical Gelatin Market
8.6.1 Italy Pharmaceutical Gelatin Market by Type
8.6.2 Italy Pharmaceutical Gelatin Market by Source
8.6.3 Italy Pharmaceutical Gelatin Market by Function
8.6.4 Italy Pharmaceutical Gelatin Market by Application
8.7 Rest of Europe Pharmaceutical Gelatin Market
8.7.1 Rest of Europe Pharmaceutical Gelatin Market by Type
8.7.2 Rest of Europe Pharmaceutical Gelatin Market by Source
8.7.3 Rest of Europe Pharmaceutical Gelatin Market by Function
8.7.4 Rest of Europe Pharmaceutical Gelatin Market by Application
Chapter 9. Company Profiles
9.1 Nitta Gelatin, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Sales Category and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Product Launches and Product Expansions:
9.2 Tessenderlo Group nv
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.3 Lonza Group Ltd. (Capsugel)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:’
9.4 Catalent, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Darling Ingredients, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 GELITA AG
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Acquisition and Mergers:
9.7 Roxlor Group
9.7.1 Company Overview
9.8 Norland Products, Inc.
9.8.1 Company Overview
9.9 SAS Gelatines Weishardt
9.9.1 Company Overview
Companies Mentioned
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Methodology
LOADING...
